-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Protalix BioTherapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
- Protalix BioTherapeutics, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $9.46M, a 53.8% increase year-over-year.
- Protalix BioTherapeutics, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $25.8M, a 38% increase year-over-year.
- Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2023 was $23M, a 17.3% increase from 2022.
- Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2022 was $19.6M, a 19.8% increase from 2021.
- Protalix BioTherapeutics, Inc. annual Cost of Revenue for 2021 was $16.3M, a 50.4% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)